New patent expiration for Takeda Pharms drug GATTEX KIT
Annual Drug Patent Expirations for GATTEX+KIT Gattex Kit is a drug marketed by Takeda Pharms Usa and is included in […]
New patent expiration for Takeda Pharms drug GATTEX KIT Read Post »
Patent Expiration
New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO
Annual Drug Patent Expirations for SUMAVEL+DOSEPRO Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in
New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO Read Post »
New patent expiration for Helsinn Hlthcare drug AKYNZEO
Annual Drug Patent Expirations for AKYNZEO Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs.
New patent expiration for Helsinn Hlthcare drug AKYNZEO Read Post »
New patent expiration for Novartis drug PATANASE
Annual Drug Patent Expirations for PATANASE Patanase is a drug marketed by Novartis and is included in one NDA. It
New patent expiration for Novartis drug PATANASE Read Post »
New patent expiration for Becton Dickinson drug CHLORAPREP WITH TINT
Annual Drug Patent Expirations for CHLORAPREP+WITH+TINT Chloraprep With Tint is a drug marketed by Becton Dickinson Co and is included
New patent expiration for Becton Dickinson drug CHLORAPREP WITH TINT Read Post »
Drug Patent Expirations for the Week of March 12, 2023
DIFFERIN (adapalene) Galderma labs lp Patent: 8,703,820 Expiration: Mar 12, 2023 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of March 12, 2023 Read Post »
New patent expiration for Array Biopharma drug MEKTOVI
Annual Drug Patent Expirations for MEKTOVI Mektovi is a drug marketed by Array Biopharma Inc and is included in one
New patent expiration for Array Biopharma drug MEKTOVI Read Post »
New patent expiration for Astrazeneca drug KOSELUGO
Annual Drug Patent Expirations for KOSELUGO Koselugo is a drug marketed by Astrazeneca and is included in one NDA. It
New patent expiration for Astrazeneca drug KOSELUGO Read Post »
New patent expiration for Galderma Labs drug EPIDUO FORTE
Annual Drug Patent Expirations for EPIDUO+FORTE Epiduo Forte is a drug marketed by Galderma Labs and is included in one
New patent expiration for Galderma Labs drug EPIDUO FORTE Read Post »
